z-logo
open-access-imgOpen Access
Is Treatment of ST-Segment–Elevation Myocardial Infarction Patients With Ticagrelor or Other P2Y 12 Inhibitors Before Primary Percutaneous Coronary Intervention a Strategy Without Benefit?
Author(s) -
Kurt Huber
Publication year - 2018
Publication title -
circulation cardiovascular interventions
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.621
H-Index - 95
eISSN - 1941-7632
pISSN - 1941-7640
DOI - 10.1161/circinterventions.118.006555
Subject(s) - ticagrelor , percutaneous coronary intervention , medicine , cardiology , myocardial infarction , st segment , elevation (ballistics) , geometry , mathematics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom